Cargando…
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors
KRAS gene mutation is widespread in tumors and plays an important role in various malignancies. Targeting KRAS mutations is regarded as the “holy grail” of targeted cancer therapies. Recently, multiple strategies, including covalent binding strategy, targeted protein degradation strategy, targeting...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146153/ https://www.ncbi.nlm.nih.gov/pubmed/37110848 http://dx.doi.org/10.3390/molecules28083615 |